Endoscopes Market Size Is Anticipated To Reach USD 17.19 Billion By 2025 | : Grand View Research Inc.

San Francisco, 31 May 2019: The Report Endoscopes Market Size, Share, And Trends Analysis Report By Product (Flexible, Disposable, Rigid), By Application (Gastrointestinal, Urology, Laparoscopy), By End Use, And Segment Forecasts, 2018 – 2025

The global endoscopes market size is expected to reach USD 17.19 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.8% during the forecast period. Growing global geriatric population, high prevalence of gastrointestinal diseases, and rising technological advancements are the key factors contributing to market growth. Rising preference for minimally invasive surgeries (MIS) is also positively influencing the growth of the market.

Endoscopy surgeries are performed for diagnosis as well as treatment of gastrointestinal, gynecological, neurological, and cardiovascular diseases. Emergence of minimally invasive alternatives to open surgeries such as laparoscopy, hysteroscopy, and colonoscopy is boosting the demand for endoscopes. Preference of MIS is increasing owing to smaller incision, reduction in postoperative complications & mortality, and lesser trauma. Furthermore, they are economically viable alternatives to open surgeries.

Availability of technologically advanced endoscopes is also providing a significant push to the market. Market players are undertaking R&D initiatives to improve existing products as well as launch new products, which is expected to bolster the growth of the market. For example, VISERA 4K UHD System is a surgical system lunched by Olympus in 2016 with 55-inch primary operative display for enhancing MIS.

In March 2018, Auris Health, Inc. announced FDA approval of its new robotic endoscopy system, Monarch Platform. In June 2017, Olympus launched 3D surgical endoscope designed to be compatible with VISERA ELITE II system. It uses 3D imaging facilitating depth perception that enables precise surgery. Pentax Medical launched Slim Linear Ultrasound Endoscope (EG-3270UK) in the U.S. in August 2017.

Access Research Report of Endoscopes Market @ www.grandviewresearch.com/industry-analysis/endoscopes-market

Further key findings from the report suggest:

• Flexible endoscopes emerged as the largest product segment in 2017, accounting for more than half of the market revenue
• Gastrointestinal endoscopy was the leading revenue contributor in the market, on the basis of applications, in 2017. On the other hand, urology endoscopy is expected to emerge as the fastest growing segment over the forecast period
• Hospitals was the largest end-use segment in 2018 in terms of revenue. Ambulatory surgery centers are rapidly gaining popularity and the segment is anticipated to register the highest CAGR during the same period
• North America was the dominant regional market in 2017 due to high healthcare expenditure, favorable reimbursement framework, growing elderly population and disease burden, and heightened adoption of technologically advanced products
• Asia Pacific is likely to exhibit a lucrative CAGR of 10.6% during the forecast period owing to economic development in emerging countries, improvement in healthcare infrastructure, and increase in awareness about MIS
• Olympus Corporation; Ethicon US, LLC; Fujifilm Holdings Corporation; Boston Scientific Corporation; Karl Storz GmbH & Co. KG; Stryker; Medtronic; and CONMED Corporation are the leading players in the endoscopes market.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global endoscopes market on the basis of product, applications, end use, and region:

Endoscopes Product Outlook (Revenue, USD Million, 2014 – 2025)

• Rigid Endoscopes
  • Laparoscopes
  • Arthroscopes
  • Urology endoscopes
  • Cystoscopes
  • Gynecology endoscopes
  • Neuroendoscopes
  • Other rigid endoscopes
• Flexible Endoscopes
  • Upper gastrointestinal endoscopes
  • Colonoscopes
  • Bronchoscopes
  • Sigmoidoscopes
  • Laryngoscopes
  • Pharyngoscopes
  • Duodenoscopes
  • Nasopharyngoscopes
  • Rhinoscopes
  • Other flexible endoscopes
• Capsule Endoscopes
• Disposable Endoscopes
• Robot Assisted Endoscopes

Endoscopes Application Outlook (Revenue, USD Million, 2014 – 2025)

• Gastrointestinal (GI) endoscopy
• Urology endoscopy (cystoscopy)
• Laparoscopy
• Obstetrics/gynecology endoscopy
• Arthroscopy
• Bronchoscopy
• Mediastinoscopy
• Otoscopy
• Laryngoscopy
• Other applications

Endoscopes End Use Outlook (Revenue, USD Million, 2014 – 2025)

• Hospitals
• Ambulatory surgery centers
• Other End Uses

Endoscopes Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Endoscopes Market @ www.grandviewresearch.com/press-release/global-endoscopes-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

U.S. Practice Management Systems Market Estimated To Expand At A CAGR Of 10.3% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 31 May 2019: The Report U.S. Practice Management Systems Market Size, Share & Trends Analysis Report By Product (Integrated, Standalone), By Component (Software, Services), By End-use, By Delivery Mode, And Segment Forecasts, 2018 – 2025

The U.S. practice management system market is expected to reach USD 11.11 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 10.3% over the forecast period. Demand for practice management system is growing due to increasing pressure to curb healthcare costs and changing dynamics of hospital/healthcare settings industry. Rising focusing on implementing cost-effective and quality care, which will boost the market demand.

Political instability, economic stress, and lack of proactive initiatives are questioning the healthcare funding. Despite healthcare-related funding and insurance programs, there has been a constant rise in healthcare cost in U.S., influencing healthcare providers. The healthcare expenditure in U.S. is around 2.4 times higher than the global average and is anticipated to increase by 68.0% in the next 10 years.

With the help of practice management systems, healthcare providers are now able to offer right treatment at effective price, thus reducing treatment costs. Some of the prominent companies in the market for U.S. practice management systems are Henry Schein MicroMD; Allscripts Healthcare Solutions, Inc.; AdvantEdge Healthcare Solutions, Inc.; Cerner Corporation; GE Healthcare; and McKesson Corporation.

Access Research Report of U.S. Practice Management Systems Market @ www.grandviewresearch.com/industry-analysis/us-practice-management-systems-market

Further key findings from the study suggest:

• Changing dynamics of healthcare settings/hospital industry along with the development and sale of value-added services is driving the market
• The integrated systems segment capturedthe largest market share in 2017 mainly due to the benefits, such as enhanced efficiency and communication across various departments and reduced administrative and medical errors
• Cloud-based practice management solutions segment is anticipated to witness the fastest growth over the forecast period
• Cloud-based practice management solutions offer benefits such as readily available information that can be accessed even in the remote locations, higher reliability, and faster processing
• Key companies in the market include Henry Schein MicroMD; Allscripts Healthcare Solutions, Inc.; AdvantEdge Healthcare Solutions, Inc.; Cerner Corporation; GE Healthcare; and McKesson Corporation.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the U.S. practice management systems market on the basis of product, component, delivery mode, and end-use:

U.S. Practice Management Systems Product Outlook (Revenue, USD Million, 2014 – 2025)

• Integrated
• Standalone

U.S. Practice Management Systems Component Outlook (Revenue, USD Million, 2014 – 2025)

• Software
• Services

U.S. Practice Management Systems Delivery Mode Outlook (Revenue, USD Million, 2014 – 2025)

• On-premise
• Web-based
• Cloud-based

U.S. Practice Management Systems End-use Outlook (Revenue, USD Million, 2014 – 2025)

• Physician Office
• Pharmacies
• Diagnostic Laboratories
• Other Settings

Access Press Release of U.S. Practice Management Systems Market @ www.grandviewresearch.com/press-release/us-practice-management-systems-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Dental 3D Printing Market Segmented On The Basis Of Application, Technology, End Use, And Region : Grand View Research Inc.

San Francisco, 31 May 2019:The global Dental 3D Printing Market size was valued at USD 1.2 billion in 2017. It is expected to register a CAGR of 29.3% during the forecast period. Rising global geriatric population and mounting cases of dental conditions are anticipated to drive the market. Apart from this, surging demand for customized dental 3D printers is likely to stimulate the growth of the market over the forecast period.

Since aged people are more susceptible to oral health issues, rising geriatric population worldwide is translating into upswing in cases of tooth replacement surgeries. As per the findings of the National Institute of Dental and Craniofacial Research, the average teeth remaining of geriatric population (aged 65 years and above) is 18.9. Thus, rise in their population is creating a highly lucrative market for dental 3D printing. Furthermore, innovative and low cost technologies are set to shape the future of the market and increase in usage rate of dental 3D printed products over the forecast period.

Access Research Report of Dental 3D Printing Market @ www.grandviewresearch.com/industry-analysis/dental-3d-printing-market

Further key findings from the report suggest:

• In terms of revenue, the selective laser sintering segment is projected to expand at a CAGR of over 29.0% during the forecast period. This segment will be the leading revenue contributor in the market throughout the forecast horizon owing to the benefits offered such as its chemical resistance, biocompatibility, and excellent surface finishing ability
• In 2025, North America dominated the market with a market share of just over 38.0%. It is expected to witness steady growth over the same period owing to supportive government initiatives and appropriate funding
• Some of the key companies present in the market are SLM Solutions; 3D Systems; ; Roland DG Corporation; Stratasys; Straumann AG GroupDentsPly Sirona Inc.; Prodways Group; Renishaw Inc.; EnvisionTEC; and FormLabs Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global dental 3D printing market report on the basis of technology, application, end-use, and region:

• Technology Outlook (Revenue, USD Million, 2014 – 2025)
  • Vat Photopolymerization
    • Stereo-lithography
    • Digital Light Processing
  • Polyjet Technology
  • Fused Deposition Modelling
  • Selective Laser Sintering
  • Others
• Application Outlook (Revenue, USD Million, 2014 – 2025)
  • Orthodontics
  • Prosthodontics
  • Implantology
• End-use Outlook (Revenue, USD Million, 2014 – 2025)
  • Dental Clinics
  • Dental Laboratories
  • Academic and Research Institutes
• Regional Outlook (Revenue, USD Million, 2014 – 2025)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Access Press Release of Dental 3D Printing Market @ www.grandviewresearch.com/press-release/global-dental-3d-printing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Prosthetics and Orthotics Market Is Witnessing An Upswing Of CAGR Of 5.1% For Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 31 May 2019: The Report Prosthetics and Orthotics Market Size, Share & Trends Analysis Report By Type (Orthotics (Upper Limb, Lower Limb, Spinal), Prosthetics (Upper Extremity, Lower Extremity), And Segment Forecasts, 2018 – 2025

The global prosthetics and orthotics market size is expected to reach USD 12.28 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 5.1% CAGR during the forecast period. Increasing incidence of sports injuries, rising incidence of osteosarcoma, and expanding geriatric population base are key factors driving market growth.

Rising geriatric population across the globe has become one of the key factors driving demand for prosthetics and orthotics. For instance, as per the United Nations, the number of people aged 60 years or over globally is expected to more than double by 2050, increasing from 962 million in 2017 to 2.1 billion in 2050. Geriatrics are more susceptible to conditions such as osteoporosis and osteopenia, making them common users of various orthopedic solutions.

Increasing incidence of osteosarcoma in young adults and children is also driving the market to a great extent. For instance, Children with Cancer UK, a member of the Association of Medical Research Charities (AMRC), reported that osteosarcoma is the most common bone tumor in children and every year around 30 new cases in children are diagnosed in U.K. Osteosarcoma is generally treated with the help of chemotherapy, surgery, and radiation. Patients recovering from this surgery generally need orthopedic devices and prosthetics as a part of post-surgery treatment, which is slated to drive the market in the upcoming years.

Access Research Report of Prosthetics and Orthotics Market @ www.grandviewresearch.com/industry-analysis/prosthetics-orthotics-market

Further key findings from the report suggest:

•  In terms of revenue, the orthotics segment is projected to ascend at a CAGR of 5.2% over the forecast period. Increasing cases of diabetes related amputations across the globe is acting as the driving factor for this segment
• By revenue, Asia Pacific is expected to exhibit the highest growth rate over the forecast period. Rising awareness and supportive government initiatives will fuel market growth
• Some of the key companies present in the market are Ossur; Zimmer Biomet Holdings Inc.; Blatchford Inc.; Fillauer LLC; Ottobock Healthcare GmbH; The Ohio Willow Wood Company; and Ultraflex Systems Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global prosthetics and orthotics market on the basis of type and region:

Prosthetics and Orthotics Type Outlook (Volume, Units Sold; Revenue, USD Million, 2014 – 2025)

• Orthotics
  • Lower limb
  • Upper limb
  • Spinal
• Prosthetics
  • Upper Extremity
  • Lower Extremity
  • Liners
  • Sockets
  • Modular Components

Prosthetics and Orthotics Region Outlook (Volume, Units Sold; Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• APAC
• LATAM
• MEA

Access Press Release of Prosthetics and Orthotics Market @ www.grandviewresearch.com/press-release/global-prosthetics-orthotics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Acne Drugs Market Is Developing At A CAGR Of 4.2% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 31 May 2019: The Report Acne Drugs Market Size, Share & Trends Analysis Report By Type, By Therapeutic Class (Retinoid, Antibiotic, Combination), By Mode of Administration (Injectable, Topical, Oral), And Segment Forecasts, 2018 – 2025

The global acne drugs market size is expected to reach USD 5.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a 4.2% CAGR during the forecast period. Several factors such as emergence of biologics, unhealthy lifestyle, and rising disease incidence are anticipated to drive the market.

Acne vulgaris is one of the most common dermatological disorders, affecting 9.4% people worldwide. Although the condition can affect people of all ages, it is most prevalent among teenagers. It has been found that the condition is prevalent in more than 85.0% people between the ages of 12 and 25. Acne can appear in forms ranging from comedones to cystic lesions, depending on its severity.

Retinoids and antibiotics remain the mainstays of acne treatment. Retinoids led the therapeutic classes in 2017, and it is expected to continue this trend through 2025. The therapeutic landscape is witnessing a shift toward combination treatment due to higher efficacy, convenient dosing, and fewer adverse effects.

By mode of administration, topical drugs currently dominate the market. Severe cases see the use of systemic medications such as oral antibiotics, hormonal agents, or other drugs. However, emergence of biologics (Gevokizumab and RA-18C3) will fuel the injectable route of administration. Biologics offer improved clinical advantage over conventional topical treatments since they target inflammatory mechanisms with disease modifying ability.

Discontinuation or termination of key pipeline candidates on account of unsuccessful clinical trials is a major restraint this market faces. Upon launch, Olumacostat glasaretil (Dermira; topical lipid synthesis inhibitor) was expected to be the first topical anti-acne drug with isotretinoin-like results without significant side effects. However, the drug failed to meet clinical endpoints, leading to discontinuation in March 2018. Similarly, SNA-001 (Sienna; silver nanoparticles solution) was deemed unsuccessful in two key trials wherein it was tested in conjunction with 810nm and 1064nm lasers in July 2018. Thesan withdrew TSN2898 from Phase II trials due to drug unavailability. Xenon discontinued development of XEN801 after the drug failed Phase II clinical trials.

Despite being one of the most common dermatological diseases in the world, innovation in acne treatment has been rather limited over the past decade. Drug companies are currently exploring novel treatment approaches including stearoyl CoA desaturase inhibition, melanocortin receptor antagonism, and anti-IL-1 monoclonal antibodies. Impending launch of late-stage pipeline products indicate a promising future for the global acne drugs market.

Access Research Report of Acne Drugs Market @ www.grandviewresearch.com/industry-analysis/acne-drugs-market

 Further key findings from the report suggest:

• By type, inflammatory acne captured more than 50.0% of the market in 2017. Comedonal acne were ranked second-largest, among other types
• On the basis of therapeutic class, retinoids led the market in 2017, followed by antibiotics. This trend is likely to continue through 2025
• The treatment paradigm is shifting toward combination therapies and biologics. Combination products are gaining traction due to higher efficacy, convenient dosing, and fewer adverse effects
• Topical products dominated the treatment landscape, based on mode of administration. However, introduction of biologics is likely to result in the growth of the injectables segment
• S. dominated the major markets and is projected to maintain its lead through 2025, owing to rising disease incidence and ease of access to anti-acne products
• Allergan, Bayer, Galderma, Stiefel, and Valeant are some key players operating in this market. Valeant is projected to lead the market in 2025 due to higher adoption of Retin-A micro as well as anticipated launch of pipeline candidates.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global acne drugs market based on type, therapeutic class, mode of administration, and country:

Acne Drugs Type Outlook (Revenue, USD Million, 2017 – 2025)

• Comedonal
• Inflammatory
• Cystic
• Post-surgical/Wound

Acne Drugs Therapeutic Class Outlook (Revenue, USD Million, 2017 – 2025)

• Retinoid
• Antibiotic
• Hormonal Agent
• Combination
• Others

Acne Drugs Mode of Administration Outlook (Revenue, USD Million, 2017 – 2025)

• Topical
• Oral
• Injectable

Acne Drugs Country Outlook (Revenue, USD Million, 2017 – 2025)

• U.S.
• U.K.
• Germany
• Spain
• France
• Italy
• Japan

Access Press Release of Acne Drugs Market @ www.grandviewresearch.com/press-release/global-acne-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Vaccine Delivery Devices Market Is Likely To Up Demand At A USD 6.21 Billion By 2025 : Grand View Research Inc.

San Francisco, 30 May 2019: The Report Vaccine Delivery Devices Market Analysis By Devices (Syringes, Jet Injectors, Other Devices), By Route of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others), And Segment Forecasts, 2018 – 2025

The global vaccine delivery devices market is expected to reach USD 6.21 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by growing immunization programs, financial support from government & nongovernment organizations, increasing vaccination initiatives & campaigns, and rising prevalence of infectious diseases globally. Growing research in the field of vaccines and development of new products is also contributing to the growth of the market.

Adoption of needle-free approach for administering these products is gaining momentum due to growing awareness and demand to avoid pain & injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling market growth. Rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.

Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the UK government also announced funding up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.

Access Research Report of Vaccine Delivery Devices Market @ www.grandviewresearch.com/industry-analysis/vaccine-delivery-devices-market

Further key findings from the report suggest:

• The syringes segment held majority of the revenue share in 2016 due to increasing vaccination programs, spreading immunization coverage, and technological advancements
• Jet injectors is expected to register highest growth during the forecast period owing to rising concerns regarding needle stick injuries and growing preference for needle-free technologies
• Intramuscular vaccination dominated the route of administration segment in 2016 as majority of vaccines are given through this route owing to its advantages
• North America dominated the global market owing to increasing awareness levels, high adoption of technology, and rising prevalence of infectious diseases
• Some of the key players include Becton Dickinson & Company, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.); Gerresheimer AG; PharmaJet; Corium International, Inc.; and SCHOTT AG.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the vaccine delivery devices market on the basis of devices, route of administration, and region:

Devices Outlook (Revenue, USD Million, 2014 – 2025)

• Syringes
• Jet Injectors
• Other Devices

Route of Administration Outlook (Revenue, USD Million, 2014 – 2025)

• Intradermal Vaccination
• Intramuscular vaccination
• Subcutaneous Vaccination
• Other Vaccinations

Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Vaccine Delivery Devices Market @ www.grandviewresearch.com/press-release/global-vaccine-delivery-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Intraoperative Imaging Market Poised To Augment The Industry At $ 4.2 Billion By 2025 : Grand View Research Inc.

San Francisco, 30 May 2019: The Report Intraoperative Imaging Market By Product (iCT, Intraoperative Ultrasound, iMRI, C-Arms Systems), By Application (Neurosurgery, Orthopedic Surgery, ENT Surgery, Oncology Surgery) By End-use, And Segment Forecasts, 2018 – 2025

The global intraoperative imaging market is expected to reach USD 4.2 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive surgeries is a major factor projected to propel growth during the forecast period. The popularity of minimally invasive surgery is rising because it is does not require major incisions, which results in reduced scarring, less pain, shorter hospital stay, and faster recovery. Various advanced intraoperative imaging devices such as Mobile C-arms, Computed Tomography (CT), Intraoperative Magnetic Resonance Imaging (iMRI), and ultrasound devices are widely used for minimally invasive surgeries.

Technological advancement is another major factor supporting market growth. Vendors are focusing on development of innovative and advanced products to cater to the unmet needs of surgeons. Advanced technologies such as iMRI provide high-quality imaging and higher precision during surgery. For instance, VISIUS iMRI delivers high-quality images and real-time data during surgical procedures.

Access Research Report of Intraoperative Imaging Market @ www.grandviewresearch.com/industry-analysis/intraoperative-imaging-market

Further Key Findings From the Report Suggest:

• Intraoperative CT systems segment was the largest revenue-grossing segment of the overall market in 2016, due to high application of these systems in image-guided neurosurgery & orthopedic surgery
• The iMRI systems segment is expected to exhibit highest growth during the forecast period owing to technological advancements and growing popularity of these systems for critical surgeries
• In the application segment, neurosurgery accounted for the largest share in 2016 and is projected to maintain its dominance throughout the forecast period
• Hospitals dominated the market in terms of revenue in 2016 because they accounted for the highest number of surgical procedures
• The North American region held the highest revenue share in 2016 and is expected to maintain its dominance during the study period due to its well-developed healthcare infrastructure.
• The Asia Pacific intraoperative imaging market is expected to grow at the highest CAGR during the forecast period because of rising disposable income, developing healthcare facilities, and increasing prevalence of neurological & orthopedic disorders.
• Some of the major players are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Medtronic, Ziehm Imaging GmbH, IMRIS, Deerfield Imaging, Shimadzu Corporation, Brainlab AG, and NeuroLogica Corp.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global intraoperative imaging market on the basis of product, application, end-use, and region:

Intraoperative Imaging Product Outlook (Revenue, USD Million; 2014 – 2025)

• iCT systems
• Intraoperative ultrasound systems
• iMRI systems
• C-arms systems

Intraoperative Imaging Application Outlook (Revenue, USD Million; 2014 – 2025)

• Neurosurgery
• Orthopedic surgery
• ENT surgery
• Oncology surgery
• Others

Intraoperative Imaging End-use Outlook (Revenue, USD Million; 2014 – 2025)

• Hospitals
• Others

Intraoperative Imaging Regional Outlook (Revenue, USD Million; 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Intraoperative Imaging Market @ www.grandviewresearch.com/press-release/global-intraoperative-imaging-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Transplantation Market Projected To Reach USD 51.0 Billion By 2025 : Grand View Research Inc.

San Francisco, 30 May 2019: The Report Transplantation Market By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solutions), By Application (Organ, Tissue Transplantation), By End-use, And Segment Forecasts, 2018 – 2025

The global transplantation market is expected to reach USD 51.0 billion by the year 2025, growing at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market. Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost growth of the market during forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for management of organ failure.

Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products  and surgical instruments has majorly contributed to the expansion of the sector. In addition, introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment.  In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, availability of such advanced techniques supports increase in the number of organ transplant procedures.

Access Research Report of Transplantation Market @ www.grandviewresearch.com/industry-analysis/transplantation-market

Further key findings from the report suggest:

• Tissue products segment was the largest revenue-generating amongst others due to escalating number of tissue and organ transplant procedures
• Tissue products segment is also expected to grow at highest CAGR owing to advancement in transplantation products
• Tissue transplant segment held the largest revenue share in the market, because of rising number of skin, bones, heart valves, cornea, tendons, nerves, and veins procedures worldwide
• The transplant centers segment is projected to grow at the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures
• The hospitals segment dominated the market in terms of revenue in 2016 owing to a large number of transplant procedures performed in hospitals
• North America was the leading regional sector in 2016 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure
• Existence of large number of research laboratories, biotechnology, and medical device companies in the North America region is the major factor contributing to its large share
• Some of the major players include AbbVie, Inc.; Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; Stryker; 21st Century Medicine; BioLifeSolutions, Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global transplantation market on the basis of product, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2014 – 2025)

• Tissue products
• Immunosuppressive drugs
• Preservation solutions

Application Outlook (Revenue, USD Billion; 2014 – 2025)

• Organ transplantation
• Tissue transplantation

End-Use Outlook (Revenue, USD Billion; 2014 – 2025)

• Hospitals
• Transplant centers
• Others

Regional Outlook (Revenue, USD Billion; 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Transplantation Market @ www.grandviewresearch.com/press-release/global-transplantation-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Erythropoietin (EPO) Drugs Market Likely To Touch At USD 17.4 Billion By 2025 : Grand View Research Inc.

San Francisco, 30 May 2019: The Report Erythropoietin (EPO) Drugs Market Analysis By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application, And Segment Forecasts, 2018 – 2025

The global erythropoietin (EPO) drugs market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of this market.

According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.

Introduction of novel drugs and their cheaper biosimilar formulations with enhanced efficacy and cost-effectiveness is also expected to serve this industry with lucrative opportunities. For instance, development of numerous biosimilars in the European market is expected to gain traction and increase their usage rates, owing to associated benefits such as less time required for approval, cost-efficiency, and enhanced therapeutic effect.

Companies are involved in extensive R&D initiatives for development of innovative molecules and discovering new therapeutic areas for existing drugs. For instance, in April 2016, Sandoz received approval from the European Commission for use of its biosimilar Binocrit in nephrology indications, thereby extending the therapeutic area of its product portfolio.

Moreover, many of the industry players in the U.S., Europe, and Asia Pacific are involved in the development of new biosimilars. For example, Biocon’s subsidiary Syngene International entered into an agreement with Bristol-Myers Squibb to extend their drug discovery and development program in India. This enables Biocon to enhance its erythropoietin drugs portfolio. Expected product approvals in the coming years are anticipated to fuel market growth.

Access Research Report of Erythropoietin (EPO) Drugs Market @ www.grandviewresearch.com/industry-analysis/erythropoietin-epo-drugs-market

Further key findings from the study suggest:

• The biologics segment is declining over the forecast period owing to patent expiration of branded biologics and introduction of biosimilars in the market
• The patent for Aranesp (darbepoetin-alfa) will expire in 2024 in the U.S. and is expected to provide numerous future growth opportunities for new market entrants
• Epoetin-alfa held the largest share of product segment owing to its early introduction in the U.S. market and patent protection
• Epoetin-omega and epoetin-zeta are anticipated to exhibit lucrative growth over the forecast period owing to associated benefits such as longer half-life and enhanced therapeutic effects
• Use of erythropoietin drugs for treatment of renal diseases held a dominant share as of 2016 owing to the increasing incidence of chronic kidney diseases
• The Asia Pacific regional industry for erythropoietin-stimulating agents is expected to witness lucrative CAGR during the forecast period
• Industry participants are focusing on the discovery of new therapeutic areas for existing drugs and development of cost-effective biosimilars, thereby increasing R&D activities for the development of erythropoietin drugs.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the erythropoietin (EPO) drugs market on the basis of the drug class, product, application, and region:

Erythropoietin Drugs Drug class Outlook (Revenue, USD Million, 2014 – 2025)

• Biologics
• Biosimilar

Erythropoietin Drugs Product Outlook (Revenue, USD Million, 2014 – 2025)

• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• Others

Erythropoietin Drugs Application Outlook (Revenue, USD Million, 2014 – 2025)

• Cancer
• Hematology
• Renal Diseases
• Neurology

Erythropoietin Drugs Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Erythropoietin (EPO) Drugs Market @ www.grandviewresearch.com/press-release/global-erythropoietin-epo-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Spirometer Market Growing At A CAGR Of 9.4% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 30 May 2019: The Report Spirometer Market Size, Share & Trends Analysis Report By Type (Hand Held, Table Top, Desktop), By Technology, By Application (Asthma, COPD, Cystic Fibrosis), By End Use, By Region, And Segment Forecasts, 2018 – 2025

The global spirometer market size is expected to reach around USD 1.3 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.4% over the forecast period. Chronic respiratory diseases are rising among adults and children worldwide. Over 2 billion people are currently estimated to be exposed to air pollution on a regular basis, driving the incidence rate of respiratory disorders. Diagnosis and monitoring of respiratory diseases has become crucial in hospitals as well as home settings.

Around 230 million people are affected by asthma across the globe. In addition, around 30% of pediatric hospitalizations are attributed to asthma. Asthma and related respiratory disorders have been increasing due to worsening environmental conditions. Spirometry is an effective method to diagnose and monitor respiratory health. The American Thoracic Society and the European Respiratory Society have been proactively working on the standardization of spirometry measurements and global guidelines.

The developed countries such as U.S. have reimbursement policies dedicated for spirometry through Medicare, Medicaid, and third-party insurance. The national spirometry amounts were increased due to revised Medicare Fee Schedule, 2018.

Access Research Report of Spirometer Market @ www.grandviewresearch.com/industry-analysis/spirometer-market

Further key findings from the report suggest:

• Steadfast increase in prevalence of Chronic Obtrusive Pulmonary Diseases (COPD) and adoption of technologically advanced diagnostic devices are some of the key drivers accountable for the growth of spirometers market across the globe
• In 2017, table top spirometers dominated the type segment in terms of revenue as they are widely used in hospitals, clinics, and other diagnostic centers
• Desktop spirometers are likely to witness the fastest growth in the coming years as the computer-based spirometry has become more popular among physicians as it reduces paperwork and offers automatic result interpretation
• Flow measurement spirometers dominated the technology segment in terms of revenue share in the year 2017. Peak flow measurement spirometers are anticipated to grow at the fastest rate over the forecast period
• Among applications, COPD held majority of the market share in 2017 pertaining to steep rise in cases of COPD across the globe. Whereas, asthma is expected to grow at the fastest rate in the years to come
• In the end use segment, hospitals and clinics held the largest market share in 2017 due to extensive use of spirometry in primary care settings. However, home healthcare is likely to experience impressive growth rate in the coming years
• North America dominated the market in terms of revenue share in 2017 as it has a large patient base with respiratory disorders. On the other hand, Asia Pacific is projected to showcase the fastest growth rate due to emerging economies such as China and India
• The market is witnessing developments of technologically advanced devices. In February 2015, Cohero Health, a U.S.-based company, received approval by the FDA for its hand held spirometer. This mobile spirometer is based on wireless technology and can be paired with computers, smart phones, and tablets for real-time monitoring and reporting
• Some of the key players in the spirometer market are Smiths Medical, Schiller AG, Nihon Kohden Corporation, and others.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global spirometer market based on type, technology, application, end use, and region:

Spirometer Type Outlook (Revenue, USD Million, 2014 – 2025)

• Hand Held
• Table Top
• Desktop

Spirometer Technology Outlook (Revenue, USD Million, 2014 – 2025)

• Volume Measurement
• Flow Measurement
• Peak Flow Measurement

Spirometer Application Outlook (Revenue, USD Million, 2014 – 2025)

• Asthma
• COPD
• Cystic Fibrosis
• Pulmonary Fibrosis
• Others

Spirometer End Use Outlook (Revenue, USD Million, 2014 – 2025)

• Hospitals & Clinics
• Home Healthcare

Spirometer Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Spirometer Market @ www.grandviewresearch.com/press-release/global-spirometer-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com